PDL BioPharma financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2023
Rev. Revenue
$96.02M $158.46M $187.34M $225.09M $294.20M $318.18M $344.98M $362.04M $374.53M $431.72M $487.46M $485.88M $197.70M $139.99M $110.52M $30.71M $0.00M $0.00M $0.00M
GM % Gross Margin %
-27.64% 1.52% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 97.94% 78.19% 56.15% 43.74% 0.00% 0.00% 0.00%
OM Operating Margin
-60.76% -20.77% 82.98% 81.71% 82.55% 93.38% 88.00% 94.93% 93.20% 93.11% 92.84% 92.57% 69.53% 10.04% -17.45% -132.08% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
95.51m 112.84m 115.23m 117.11m 119.51m 119.67m 139.53m 139.83m 139.93m 140.05m 162.46m 163.58m 165.54m 154.34m 145.98m 114.18m 113.98m 0m 0m
OCF Operating Cash Flow
$-27.16M $31.55M $78.77M $66.97M $80.15M $186.95M $184.30M $169.78M $212.51M $269.75M $292.28M $301.47M $101.72M $40.62M $-13.43M $-32.44M $0.00M $0.00M $0.00M
FCF Free Cash Flow
$-122.84M $-9.72M $23.47M $-27.73M $76.88M $186.91M $0.00M $169.78M $210.17M $0.00M $292.23M $301.46M $3.76M $39.32M $-17.95M $-33.20M $0.00M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$-1.29 $-0.09 $0.23 $-0.24 $0.65 $1.57 $1.46 $1.22 $1.52 $0.20 $1.98 $1.41 $0.70 $1.64 $0.27 $-0.25 $0.00 $0.00 $0.00